Table 1.

Characteristics of studies included in the meta-analysis

First author （year）[reference]	PubMed ID	Vaccine	Subject number	Platform	Total Probe
Nakaya HI et al. (2011)2	21743478	Influenza	65/124	HGU133 plus 2	54675
Nakaya HI et al. (2011)2	21743478	Influenza	65/124	HTHGU133 plus PM	54715
Vahey MT et al. (2010)23	20078211	malaria	12/24	HGU133A 2.0	22277
Querec TD et al. (2009)3	19029902	yellow fever	15/36	HGU133 plus 2	54675
Gaucher D et al. (2008)4	19047440	yellow fever	15/29	Illumina HRef8v2.0	22185
Obermoser G et al. (2013)22	23601689	pneumovax	9/23	Illumina HHT12v3.0	49576
Obermoser G et al. (2013)22	23601689	influenza	29/66	Illumina HHT12v3.0	49576

Note: Subject number shows pre/post vaccination.